|
|
News Breaks | | | | September 10, 2012 | | 17:22 EDT |  | KIPS | Kips Bay Medical reports first US. patient enrollment in eMESH trial
Manny Villafaña, Chairman and CEO of Kips Bay Medical announced that on August 31, the first patient was enrolled in the Kips Bay Medical eMESH I clinical feasibility trial at the Bern University Hospital, Bern, Switzerland, by Lars Englberger, MD, Senior Consultant Cardiac Surgeon who stated, “The patient had a smooth and uneventful implant of an eSVS Mesh graft and is doing very well after quadruple bypass surgery. I am looking forward to the results of this well-designed, randomized, multicenter study of the eSVS Mesh.” Dr. Englberger further commented, “I think that the eSVS Mesh® will be a very valuable tool to increase mid- and long-term patency of saphenous vein grafts, further improving clinical outcomes of patients undergoing CABG surgery by lowering the need for coronary re-interventions.” | |
|
News For KIPS From The Last 14 Days Check below for free stories on KIPS the last two weeks. |
|
|
| May 9, 2013 | | 08:46 EDT |  | KIPS | Kips Bay Medical reports Q1 EPS (5c) vs. (8c) a year ago
 Subscribe for More Information | |
|
|
|
|
|
|
